About Poniard Pharmaceuticals (OTCMKTS:PARD)
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Poniard Pharmaceuticals (OTCMKTS:PARD) Frequently Asked Questions
What is Poniard Pharmaceuticals' stock symbol?
Poniard Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PARD."
Who are some of Poniard Pharmaceuticals' key competitors?
Some companies that are related to Poniard Pharmaceuticals include Savient Pharmaceuticals (SVNTQ), UniTek Global Services (UNTKQ), diaDexus (DDXS), Directview (DIRV), Corinthian Colleges (COCOQ), Imaging Canada Liquidating (IMRSQ), Velti (VELTF), International Shipholding (ISHCQ), China Gerui Adv Mtals Grp (CHOPF), Echo Therapeutics (ECTE), Cache (CACH), Gordmans Stores (GMANQ), Kid Brands (KIDB), NephroGenex (NRXGQ), School Specialty (SCHSQ), ITT Educational Services (ESINQ), Local (LOCMQ) and Body Central (BODY).
Who are Poniard Pharmaceuticals' key executives?
Poniard Pharmaceuticals' management team includes the folowing people:
- Ronald A. Martell, Chairman of the Board (Age 54)
- Robert S. Basso, Independent Director (Age 67)
- Frederick B. Craves Ph.D., Independent Director (Age 70)
- Carl S. Goldfischer M.D., Independent Director (Age 58)
- Robert M. Littauer, Independent Director (Age 56)
- David R. Stevens Ph.D., Independent Director (Age 67)
How do I buy Poniard Pharmaceuticals stock?
Shares of Poniard Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Poniard Pharmaceuticals' stock price today?
One share of Poniard Pharmaceuticals stock can currently be purchased for approximately $0.04.
How big of a company is Poniard Pharmaceuticals?
Poniard Pharmaceuticals has a market capitalization of $70,000.00.
How can I contact Poniard Pharmaceuticals?
Poniard Pharmaceuticals' mailing address is 750 BATTERY STREET SUITE 330, SAN FRANCISCO CA, 98119-4114. The biopharmaceutical company can be reached via phone at 206-286-2501 or via email at [email protected]
MarketBeat Community Rating for Poniard Pharmaceuticals (PARD)MarketBeat's community ratings are surveys of what our community members think about Poniard Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Poniard Pharmaceuticals (OTCMKTS:PARD) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Poniard Pharmaceuticals (OTCMKTS:PARD) Earnings History and Estimates Chart
Poniard Pharmaceuticals (OTCMKTS PARD) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Poniard Pharmaceuticals (OTCMKTS:PARD) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Poniard Pharmaceuticals (OTCMKTS:PARD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Poniard Pharmaceuticals (OTCMKTS PARD)
No insider trades for this company have been tracked by MarketBeat.com
Poniard Pharmaceuticals (OTCMKTS PARD) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Poniard Pharmaceuticals (OTCMKTS:PARD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Poniard Pharmaceuticals (OTCMKTS:PARD) Income Statement, Balance Sheet and Cash Flow Statement
Poniard Pharmaceuticals (OTCMKTS PARD) Stock Chart for Tuesday, February, 20, 2018